Global Cardiac Surgical Devices Market Size By Type (Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment), By Application (Congenital Heart Defects, Cardiac Arrhythmia), By Region, And Seg...

The Global Cardiac Surgical Devices Market was valued at USD 4.1 billion in 2023 and is projected to surpass USD 7.4 billion by 2031, growing at a CAGR of 7.6% during the forecast period from 2023 to 2031. The increasing prevalence of cardiovascular diseases, aging population, advancements in surgical technologies, and a growing number of open-heart and minimally invasive surgeries are driving market expansion. The adoption of cutting-edge devices such as robotic-assisted surgical systems, heart-lung machines, and advanced catheters is transforming the cardiac surgery landscape, enhancing procedural success and patient outcomes.

Drivers:

Rising Burden of Cardiovascular Diseases:

The global increase in conditions like coronary artery disease, arrhythmias, and heart valve disorders is significantly fueling the demand for cardiac surgical procedures, thereby boosting device utilization.

Technological Advancements:

Innovation in surgical devices, including the development of minimally invasive tools and robotic-assisted platforms, has improved procedural accuracy, reduced recovery time, and enhanced patient safety.

Growth in Geriatric Population:

With age being a primary risk factor for cardiac ailments, the rise in the elderly population globally is contributing to increased demand for cardiac surgeries and associated medical devices.

Restraints:

High Cost of Cardiac Surgical Procedures:

Advanced cardiac surgical devices and associated treatments involve high costs, which can restrict adoption, especially in low- and middle-income regions lacking sufficient insurance coverage.

Risk of Surgical Complications:

Despite technological progress, surgical risks such as infections, bleeding, or device malfunction remain concerns that could hinder the market's growth.

Opportunity:

Expansion in Emerging Markets:

Countries in Asia-Pacific, Latin America, and Africa are witnessing improvements in healthcare infrastructure and increased healthcare spending, providing lucrative opportunities for market players.

Integration of AI and Robotics:

The integration of artificial intelligence and robotics into cardiac surgical procedures offers significant potential for precision surgery and real-time decision support, opening new avenues for market development.

Market by System Type Insights:

By system type, Heart-Lung Machines held the largest market share in 2023. These machines are indispensable for open-heart surgeries, maintaining circulation and oxygenation during operations. However, the robotic-assisted surgical systems segment is projected to register the fastest growth, driven by increasing adoption of minimally invasive surgeries and enhanced accuracy.

Market by End-use Insights:

In terms of end-use, hospitals and cardiac centers dominated the market in 2023, accounting for over 65% of revenue share. Their well-established infrastructure, availability of skilled surgeons, and high patient inflow make them the preferred setting for cardiac surgeries. The ambulatory surgical centers segment is expected to grow significantly, propelled by the trend toward cost-effective outpatient cardiac interventions.

Market by Regional Insights:

North America emerged as the leading region in the cardiac surgical devices market in 2023, supported by advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of cutting-edge technologies. Asia-Pacific is expected to witness the fastest CAGR during the forecast period, due to rising cardiovascular disease prevalence, growing medical tourism, and government investments in healthcare modernization.

Competitive Scenario:

Leading players in the global cardiac surgical devices market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Terumo Corporation, Getinge AB, LivaNova PLC, and B. Braun Melsungen AG. These companies are actively pursuing strategies like R&D investment, product launches, acquisitions, and partnerships to strengthen their global footprint.

Recent Developments:

2023: Medtronic launched a next-generation robotic-assisted cardiac surgery platform, improving procedural precision and reducing intraoperative risks.

2024: Abbott Laboratories introduced an AI-integrated transcatheter device for mitral valve repair, gaining FDA approval.

2025: Edwards Lifesciences announced expansion of its transcatheter heart valve manufacturing plant in Ireland, aimed at meeting rising global demand.

Scope of Work – Global Cardiac Surgical Devices Market

Report Metric Details

Market Size (2023) USD 4.1 billion

Projected Market Size (2031) USD 7.4 billion

CAGR (2023–2031)